Core Viewpoint - The company has announced the termination of using raised funds for certain projects and the adjustment of investment amounts for some fundraising projects to enhance the efficiency of fund usage and accelerate strategic business layout [2] Summary by Relevant Sections Fund Usage Adjustment - The company plans to change the use of raised funds, specifically terminating the "Electronic Chemical Research Center Construction Project" and reallocating the funds to the "40,000 tons/year Ultra-Pure Electronic Chemicals Project (Shanghai)" [2] - The total investment for the "40,000 tons/year Ultra-Pure Electronic Chemicals Project (Shanghai)" has been adjusted from 570.99 million to 793.38 million [2] Project Investment Details - The revised investment allocation for the projects is as follows: - 30,000 tons/year Electronic Grade Phosphoric Acid Project (New Construction): Total Investment 419.47 million, Raised Funds 106.36 million - 40,000 tons/year Ultra-Pure Electronic Chemicals Project (Shanghai): Total Investment 793.38 million, Raised Funds 738.31 million - 20,000 tons/year Electronic Grade Ammonia and 10,000 tons/year Electronic Grade Ammonia Gas Project: Total Investment 255.73 million, Raised Funds 226.38 million - Total Investment across all projects: 1,468.58 million, Total Raised Funds: 1,071.04 million [2] Strategic Implications - The adjustments are aimed at maximizing the effectiveness of raised fund usage, improving the quality of project implementation, and aligning with the company's long-term development strategy [2]

Investment Rating - Maintain 'Outperform' rating for the company, indicating expected performance above the market benchmark over the next 12-18 months [4][9]. Core Views - Despite challenges in glyphosate and silicone sectors, the company achieved stable growth in 2024, supported by its growth and resource sectors [4][9]. - The earnings forecasts for 2025-2026 have been lowered due to the lack of recovery in agrochemical and silicone sectors, with new forecasts for 2027 introduced [4][9]. - The target price is maintained at 24.34 RMB, corresponding to a PE ratio of 14.5x for 2025, which is above the average of 11.5x for comparable companies, reflecting optimism about the dual main business elasticity [4][9]. Financial Summary - 2024 revenue is projected at 28.40 billion RMB, a slight increase of 0.41% year-on-year, with net profit attributable to shareholders at 1.60 billion RMB, up 14.33% [4][9]. - The fourth quarter of 2024 saw revenue of 6.35 billion RMB, a year-on-year increase of 1.70%, but a quarter-on-quarter decrease of 26.60%, with net profit of 287 million RMB, down 35.82% year-on-year and down 43.63% quarter-on-quarter [4][9]. - The company plans to focus on phosphate expansion and downstream fine products capacity in 2025, aiming to complete several key projects within the year [4][9]. Financial Projections - EPS for 2025-2027 is projected to be 1.68, 1.93, and 2.19 RMB respectively, with previous estimates for 2025-2026 being 2.01 and 2.25 RMB [4][9]. - The company aims to complete various projects, including 40,000 tons/year ultra-high purity electronic chemicals and electronic-grade hydrogen peroxide expansion projects [4][9]. - Significant profit increases are expected from phosphate and specialty chemicals sectors, demonstrating resilience from deep industry chain cultivation [4][9].